Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease
Sekar Kathiresan, co-founder and CEO of Verve Therapeutics, on a gene edited single shot for cardiovascular disease.
Head of Obesity Research; formerly Co-founder and CEO, Verve Therapeutics, Lilly (Eli)
Verified interview transcripts, podcast appearances, and direct quotes from Sekar Kathiresan, Head of Obesity Research; formerly Co-founder and CEO, Verve Therapeutics at Lilly (Eli). AI-verified speaker identity with full-text searchable transcripts.
Sekar Kathiresan, co-founder and CEO of Verve Therapeutics, on a gene edited single shot for cardiovascular disease.
Sign in to search the full transcript archive, filter by topic, and access every quote from Sekar Kathiresan.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans